GlassScriptPhysician profile
Adam Daniel Finkelstein
NPI 1750471678
$2,814.21
in general payments reported to CMS, 2019-2025
20 companies · $881 in 2025
The $881 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $1,172 · 2021: $164 · 2022: $95.49 · 2023: $45.87 · 2024: $164 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $764 · Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $764.00 |
| Food and Beverage | $326.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $1,823.00 | 2020-2025 | |
| Bard Peripheral Vascular, INC. | $257.36 | 2019-2022 | |
| Boston Scientific Corporation | $160.44 | 2019-2024 | Eluvia, Ekosonic |
| Terumo Medical Corporation | $102.74 | 2019-2023 | Glidesheath Slender, Glidewire, Angio-Seal |
| Stryker Corporation | $46.15 | 2025 | Clottriever Bold Catheter |
| Exelixis INC. | $44.46 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.41 | 2020 | |
| Surmodics, INC. | $36.57 | 2024 | Pounce Venous Thrombectomy System |
| Cordis US Corp. | $36.56 | 2024-2025 | Mynx Control, Outback |
| Inari Medical, INC. | $32.16 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.14 | 2019-2020 | |
| Abbott Laboratories | $28.06 | 2025 | Perclose Prostyle |
| Teleflex LLC | $27.91 | 2024 | Arrow |
| Shockwave Medical, INC | $25.52 | 2025 | |
| Ekos Corporation | $24.64 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $22.75 | 2020 | |
| Medtronic, INC. | $20.78 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $19.55 | 2019 | |
| Becton, Dickinson and Company | $18.22 | 2024 | Lutonix Drug Coated Balloon |
| Angiodynamics, INC. | $17.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Finkelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.